Stryker Ownership
| SYK Stock | USD 388.14 1.57 0.40% |
Shares in Circulation | First Issued 1985-09-30 | Previous Quarter 385.4 M | Current Value 385.6 M | Avarage Shares Outstanding 384.4 M | Quarterly Volatility 21.2 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Stryker |
Stryker Stock Ownership Analysis
About 80.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 2.72. Stryker recorded earning per share (EPS) of 9.31. The entity last dividend was issued on the 30th of September 2024. The firm had 2:1 split on the 17th of May 2004. Stryker Corporation operates as a medical technology company. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan. Stryker Corp operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 46000 people. To find out more about Stryker contact Kevin Lobo at 269 385 2600 or learn more at https://www.stryker.com.Besides selling stocks to institutional investors, Stryker also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Stryker's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Stryker's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Stryker Quarterly Liabilities And Stockholders Equity |
|
Stryker Insider Trades History
About 5.0% of Stryker are currently held by insiders. Unlike Stryker's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Stryker's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Stryker's insider trades
Stryker Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Stryker is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Stryker backward and forwards among themselves. Stryker's institutional investor refers to the entity that pools money to purchase Stryker's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Bank Of New York Mellon Corp | 2024-06-30 | 5.7 M | Fundsmith Llp | 2024-09-30 | 5.3 M | Norges Bank | 2024-06-30 | 5 M | Fisher Asset Management, Llc | 2024-09-30 | 4.2 M | Franklin Resources Inc | 2024-09-30 | 4 M | First Western Trust Bank | 2024-09-30 | 3.5 M | Bank Of America Corp | 2024-06-30 | 3.2 M | Northern Trust Corp | 2024-09-30 | 3.2 M | Legal & General Group Plc | 2024-06-30 | 2.8 M | Vanguard Group Inc | 2024-09-30 | 32.4 M | Blackrock Inc | 2024-06-30 | 26.8 M |
Stryker Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Stryker insiders, such as employees or executives, is commonly permitted as long as it does not rely on Stryker's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Stryker insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Spencer Stiles over three months ago Acquisition by Spencer Stiles of 8499 shares of Stryker subject to Rule 16b-3 | ||
Yin Becker over six months ago Acquisition by Yin Becker of 3060 shares of Stryker at 339.77 subject to Rule 16b-3 | ||
Ramesh Subrahmanian over a year ago Payment of 2378 shares by Ramesh Subrahmanian of Stryker subject to Rule 16b-3 |
Stryker's latest congressional trading
Congressional trading in companies like Stryker, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Stryker by those in governmental positions are based on the same information available to the general public.
| 2024-11-11 | Representative Ro Khanna | Acquired Under $15K | Verify | ||
| 2024-10-08 | Representative Ro Khanna | Acquired Under $15K | Verify | ||
| 2023-01-25 | Representative Michael C Burgess | Acquired $100K to $250K | Verify | ||
| 2022-11-29 | Representative Michael C Burgess | Acquired Under $15K | Verify | ||
| 2022-11-15 | Representative Michael C Burgess | Acquired Under $15K | Verify | ||
| 2022-09-20 | Representative Michael C Burgess | Acquired Under $15K | Verify | ||
| 2022-06-03 | Representative Michael C Burgess | Acquired Under $15K | Verify | ||
| 2022-04-29 | Representative Michael C Burgess | Acquired Under $15K | Verify | ||
| 2022-04-15 | Representative Michael C Burgess | Acquired Under $15K | Verify | ||
| 2022-03-23 | Representative Michael C Burgess | Acquired Under $15K | Verify | ||
| 2021-11-17 | Representative Michael C Burgess | Acquired Under $15K | Verify |
Stryker Outstanding Bonds
Stryker issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Stryker uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Stryker bonds can be classified according to their maturity, which is the date when Stryker has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| STRYKER P 41 Corp BondUS863667AE17 | View | |
| STRYKER P 3375 Corp BondUS863667AH48 | View | |
| STRYKER P 4375 Corp BondUS863667AG64 | View | |
| STRYKER P 4625 Corp BondUS863667AJ04 | View | |
| STRYKER P 35 Corp BondUS863667AN16 | View | |
| STRYKER P 365 Corp BondUS863667AQ47 | View | |
| STRYKER PORATION Corp BondUS863667AY70 | View | |
| US863667AZ46 Corp BondUS863667AZ46 | View |
Stryker Corporate Filings
F4 | 19th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10Q | 30th of October 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 29th of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 12th of September 2024 Certification of the accuracy of the financial statements and disclosures | ViewVerify |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.2 | Dividend Share 3.2 | Earnings Share 9.31 | Revenue Per Share 57.728 | Quarterly Revenue Growth 0.119 |
The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.